Imprimis Pharmaceuticals Inc. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals Inc.

Imprimis Pharmaceuticals Inc.
Stock Exchange	NASDAQ Stock Market
EPS	$0.47
Market Cap	$62.94 M
Shares Outstanding	21.05 M
Public Float	19.18 M

Profile

Address	12264 El Camino Real San Diego California 92130 United States
Employees	-
Website	http://www.imprimispharma.com
Updated	09/14/2018
Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J.

Financials

Robert J. Kammer

Chairman

Mark L. Baum

Chief Executive Office & Director